Get started
Author

Haojie Si

Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas
2023 · Junqiang Fan, Jie Yao, et al. · Lung Cancer · 23
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non–small cell lung cancer
2024 · Long Xu, Haojie Si, et al. · Journal of Thoracic and Cardiovascular Surgery · 17
Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma
2024 · Haojie Si, Long Xu, et al. · The Annals of Thoracic Surgery · 17
PDF
The number of metastatic lymph nodes is more predictive of prognosis than location-based N stage for nonsmall cell lung cancer: a retrospective cohort study
2023 · Long Xu, Haojie Si, et al. · International Journal of Surgery · 11
Development of the semi-dry dot-blot method for intraoperative detecting micropapillary component in lung adenocarcinoma based on proteomics analysis
2023 · Long Xu, Hang Su, et al. · British Journal of Cancer · 3
PDF
Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically Resected Non-Small Cell Lung Cancer
2025 · Jialiang Wen, Yichen Dong, et al. · The Annals of Thoracic Surgery · 2
A machine learning model integrating circulating Temra cell transcriptional profiles to predict immunotherapy efficacy
2026 · Yichen Dong, Xuanhao Xu, et al. · Med · 1
Validation and refinement of the ninth edition ypN descriptor in patients with non−small cell lung cancer receiving neoadjuvant therapy
2025 · Haojie Si, Yuntao Feng, et al. · Journal of Thoracic and Cardiovascular Surgery · 1
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
2024 · Yichen Dong, Long Xu, et al. · JTO Clinical and Research Reports · 1
PDF
Explainable machine learning for predicting grade ≥3 treatment-related adverse events in resectable non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy: predominant contribution of hematologic toxicity
2026 · Fei-Hang Zhi, Yunzeng Zhang, et al. · Translational Lung Cancer Research
Optimizing neoadjuvant chemoimmunotherapy cycles based on radiologic response improves efficacy and survival in non-small cell lung cancer
2026 · Jingyu Chen, Yichen Dong, et al. · Translational Lung Cancer Research
Works count: 11
Citation count: 76
H-index: 4
I10-index: 4
Year
Topic
Type